Finally, although we report a positive trend towards longer OS in men receiving ASi, this should be interpreted with caution, since patients’ subsequent therapies were considerably heterogeneous, which could have a crucial effect on OS.
← all excerpts
Angiotensin System Inhibitors May Improve Outcomes of Patients With Castration-Resistant Prostate Cancer During Abiraterone Acetate Treatment-A Cardio-Oncology Study.
1
—
—